Methodological recommendations (draft). Systemic lupus erythematosus: Diagnosis, treatment, monitoring (short version)


DOI: https://dx.doi.org/10.18565/therapy.2025.1.8-15

Popkova T.V., Panafidina T.A., Lila A.M.

Abstract. Current guidelines are intended for primary care specialists: therapists, general practitioners, and senior medical students. They include basic concepts on clinical course, diagnosis, treatment, monitoring, and prognosis of patients with systemic lupus erythematosus. The material of the guide is presented in adapted sections from modern clinical guidelines of specialized societies, as well as current federal regulatory documents.

Literature


1. Насонов Е.Л., Соловьев С.К., Аршинов А.В. Системная красная волчанка: история и современность. Научно-практическая ревматология. 2022; 60(4): 397–412. [Nasonov E.L., Solovyev S.K., Arshinov A.V. Systemic lupus erythematosus: History and modernity. Nauchcno-practicheskaya revmatologiya = Rheumatology Science and Practice. 2022; 60(4): 397–412 (In Russ.)].


https://doi.org/10.47360/1995-4484-2022-397-412. EDN: FGMZBY.


2. Allen M.E., Rus V., Szeto G.L. Leveraging heterogeneity in systemic lupus erythematosus for new therapies. Trends Mol Med. 2021; 27(2): 152–71.


https://doi.org/10.1016/j.molmed.2020.09.009. PMID: 33046407. PMCID: PMC8667782.


3. Piga M., Arnaud L. The main challenges in systemic lupus erythematosus: Where do we stand? J Clin Med. 2021; 10(2): 243.


https://doi.org/10.3390/jcm10020243. PMID: 33440874. PMCID: PMC7827672.


4. Moss K.E., Ioannou Y., Sultan S.M. et al. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis. 2002; 61(5): 409–13.


https://doi.org/10.1136/ard.61.5.409. PMID: 11959764. PMCID: PMC1754082.


5. Fava A., Petri M. Systemic lupus erythematosus: Diagnosis and clinical management. J Autoimmun. 2019; 96: 1–13.


https://doi.org/10.1016/j.jaut.2018.11.001. PMID: 30448290. PMCID: PMC6310637.


6. Petri M., Orbai A.-M., Alarcon G.S. et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012; 64(8): 2677–86.


https://doi.org/10.1002/art.34473. PMID: 22553077. PMCID: PMC3409311.


7. Allen M.E., Rus V., Szeto G.L. Leveraging heterogeneity in systemic lupus erythematosus for new therapies. Trends Mol Med. 2021; 27(2): 152–71.


https://doi.org/10.1016/j.molmed.2020.09.009. PMID: 33046407. PMCID: PMC8667782.


8. Козловская Н.Л., Соловьев С.К., Асеева Е.А. с соавт. Обновленные рекомендации EULAR/ERA-EDTA 2019 г. по терапии волчаночного нефрита. Комментарии экспертов. Часть I. Современная ревматология. 2020; 14(4): 7–15. [Kozlovskaya N.L., Solovyev S.K., Aseeva E.A. et al. The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part I. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2020; 14(4): 7–15 (In Russ.)].


https://doi.org/10.14412/1996-7012-2020-4-7-15. EDN: JHNEPE.


9. Козловская Н.Л., Соловьев С.К., Асеева Е.А. с соавт. Обновленные рекомендации EULAR/ERA-EDTA 2019 г. по терапии волчаночного нефрита. Комментарии экспертов. Часть II. Современная ревматология. 2021; 15(1): 9–14. [Kozlovskaya N.L., Solovyev S.K., Aseeva E.A. et al. The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part II. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2021; 15(1): 9–14 (In Russ.)].


https://doi.org/10.14412/1996-7012-2021-1-9-14. EDN: GOGYEL.


10. Gladman D.D., Ibanez D., Urowitz M.B. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29(2): 288-91. PMID: 11838846.


11. Gladman D., Ginzler E., Goldsmith C. et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics / American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996; 39(3): 363–69.


https://doi.org/10.1002/art.1780390303. PMID: 8607884.


12. Соловьев С.К., Асеева Е.А., Попкова Т.В. с соавт. Системная красная волчанка: новые горизонты диагностики и терапии. Научно-практическая ревматология. 2020; 58(1): 5–14. [Solovyev S.K., Aseeva E.A., Popkova T.V. et al. Systemic lupus erythematosus: new horizons for diagnosis and therapy. Nauchcno-practicheskaya revmatologiya = Rheumatology Science and Practice. 2020; 58(1): 5–14 (In Russ.)].


https://doi.org/10.14412/1995-4484-2020-5-14. EDN: EABLZO.


13. Попкова Т.В., Панафидина Т.А., Соловьев С.К. По материалам обновленных рекомендаций Европейской антиревматической лиги (EULAR) по лечению системной красной волчанки – 2019: дискуссионные вопросы и комментарии. Научно-практическая ревматология. 2019; 57(5): 496–510. [Popkova T.V., Panafidina T.A., Solovyev S.K. According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: Debatable issues and comments. Nauchcno-practicheskaya revmatologiya = Rheumatology Science and Practice. 2019; 57(5): 496–510 (In Russ.)].


https://doi.org/10.14412/1995-4484-2019-496-510. EDN: NPUUDI.


14. Fanouriakis A., Kostopoulou M., Andersen J. et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024; 83(1): 15–29.


https://doi.org/10.1136/ard-2023-224762. PMID: 37827694.


15. Панафидина Т.А., Попкова Т.В., Соловьев С.К. Мониторинг больных системной красной волчанкой: общая характеристика и дискуссионные вопросы (по материалам рекомендаций Канадской ассоциации ревматологов). Научно-практическая ревматология. 2019; 57(3): 255–264. [Panafidina T.A., Popkova T.V., Solovyev S.K. Monitoring patients with systemic lupus erythematosus: general characteristics and discussion questions (according to the Canadian Rheumatology Association recommendations). Nauchcno-practicheskaya revmatologiya = Rheumatology Science and Practice. 2019; 57(3): 255–264 (In Russ.)].


https://doi.org/10.14412/1995-4484-2019-255-264. EDN: AVYPVR.


About the Autors


WORKING GROUP MEMBERS
POPKOVA T.V., MD, Dr. Sci. (Medicine), head of the Department of systemic lupus erythematosus, V.A. Nasonova Research Institute of Rheumatology, Moscow
PANAFIDINA T.A., MD, PhD (Medicine), senior researcher at the Department of systemic lupus erythematosus, V.A. Nasonova Research Institute of Rheumatology, Moscow
LILA A.M., MD, Dr. Sci. (Medicine), professor, corresponding member of RAS, director of V.A. Nasonova Research Institute of Rheumatology, head of the Department of rheumatology, Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of Russia, chief rheumatologist of the Ministry of Healthcare of Russia, Honored Doctor of the Russian Federation, Moscow


Бионика Медиа